Failure of innate and adaptive immune responses in controlling hepatitis C virus infection

FEMS Microbiology Reviews

Volumn 36, Issue 3, 2012, Pages 663-683

  Thimme, Robert ^a   Binder, Marco ^b   Bartenschlager, Ralf ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

HCV; Immune escape; Interferon; MAVS; Persistence; T cell failure

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CLAUDIN 1; EPITOPE; GAMMA INTERFERON; HLA A3 ANTIGEN; HLA B27 ANTIGEN; INTERFERON; INTERFERON REGULATORY FACTOR 3; JANUS KINASE 1; MYELOID DIFFERENTIATION FACTOR 88; OCCLUDIN; PROTEIN KINASE R; RETINOIC ACID INDUCIBLE PROTEIN I; STAT PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 3; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR;

ADAPTIVE IMMUNITY; ANTIBODY RESPONSE; ANTIVIRAL ACTIVITY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; CYTOTOXICITY; DENDRITIC CELL; HEPATITIS C; HEPATITIS C VIRUS; HOST; HUMAN; HUMORAL IMMUNITY; IN VITRO STUDY; INNATE IMMUNITY; LIVER CELL; LYMPHOCYTE FUNCTION; NATURAL KILLER CELL; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PERSISTENT VIRUS INFECTION; PROTEIN PHOSPHORYLATION; REGULATORY T LYMPHOCYTE; REVIEW; RNA REPLICATION; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; UPREGULATION; VIRAL CLEARANCE; VIRION; VIRUS ENTRY; VIRUS GENE; VIRUS INTERFERENCE; VIRUS REPLICATION;

ADAPTIVE IMMUNITY; HEPACIVIRUS; HEPATITIS C; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE EVASION; IMMUNITY, INNATE;

HEPATITIS C VIRUS;

EID: 84859432807     PISSN: 01686445     EISSN: 15746976     Source Type: Journal    
DOI: 10.1111/j.1574-6976.2011.00319.x     Document Type: Review

References (209)

1. Abel M, Sene D, Pol S, Bourliere M, Poynard T, Charlotte F, Cacoub P & Caillat-Zucman S (2006) Intrahepatic virus-specific IL-10-producing CD8 T cells prevent liver damage during chronic hepatitis C virus infection. Hepatology 44: 1607-1616.
2. Accapezzato D, Francavilla V, Paroli M, Casciaro M, Chircu LV, Cividini A, Abrignani S, Mondelli MU & Barnaba V (2004) Hepatic expansion of a virus-specific regulatory CD8(+) T cell population in chronic hepatitis C virus infection. J Clin Invest 113: 963-972.
3. Ahlenstiel G, Titerence RH, Koh C et al. (2010) Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent manner. Gastroenterology 138: 325-335.
4. Ait-Goughoulte M, Kanda T, Meyer K, Ryerse JS, Ray RB & Ray R (2008) Hepatitis C virus genotype 1a growth and induction of autophagy. J Virol 82: 2241-2249.
5. Amadei B, Urbani S, Cazaly A, Fisicaro P, Zerbini A, Ahmed P, Missale G, Ferrari C & Khakoo SI (2010) Activation of natural killer cells during acute infection with hepatitis C virus. Gastroenterology 138: 1536-1545.
6. Arnaud Nl, Dabo SP, Maillard P et al. (2010) Hepatitis C virus controls interferon production through PKR activation. PLoS ONE 5: e10575.
7. Balachandran S, Roberts PC, Brown LE, Truong H, Pattnaik AK, Archer DR & Barber GN (2000) Essential role for the dsRNA-dependent protein kinase PKR in innate immunity to viral infection. Immunity 13: 129-141.
8. Bankwitz D, Steinmann E, Bitzegeio J et al. (2010) Hepatitis C virus hypervariable region 1 modulates receptor interactions, conceals the CD81 binding site, and protects conserved neutralizing epitopes. J Virol 84: 5751-5763.
9. Bartosch B, Bukh J, Meunier JC, Granier C, Engle RE, Blackwelder WC, Emerson SU, Cosset FL & Purcell RH (2003) In vitro assay for neutralizing antibody to hepatitis C virus: evidence for broadly conserved neutralization epitopes. P Natl Acad Sci USA 100: 14199-14204.
10. Bellecave P, Sarasin-Filipowicz M, Donze O et al. (2010) Cleavage of mitochondrial antiviral signaling protein in the liver of patients with chronic hepatitis C correlates with a reduced activation of the endogenous interferon system. Hepatology 51: 1127-1136.
11. Bengsch B, Spangenberg HC, Kersting N, Neumann-Haefelin C, Panther E, von Weizsacker F, Blum HE, Pircher H & Thimme R (2007) Analysis of CD127 and KLRG1 expression on hepatitis C virus-specific CD8+ T cells reveals the existence of different memory T-cell subsets in the peripheral blood and liver. J Virol 81: 945-953.
12. Bengsch B, Seigel B, Ruhl M, Timm J, Kuntz M, Blum HE, Pircher H & Thimme R (2010) Coexpression of PD-1, 2B4, CD160 and KLRG1 on exhausted HCV-specific CD8+ T cells is linked to antigen recognition and T cell differentiation. PLoS Pathog 6: e1000947.
13. Bigger CB, Brasky KM & Lanford RE (2001) DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection. J Virol 75: 7059-7066.
14. Bigger CB, Guerra B, Brasky KM, Hubbard G, Beard MR, Luxon BA, Lemon SM & Lanford RE (2004) Intrahepatic gene expression during chronic hepatitis C virus infection in chimpanzees. J Virol 78: 13779-13792.
15. Billerbeck E, Kang YH, Walker L et al. (2010) Analysis of CD161 expression on human CD8+ T cells defines a distinct functional subset with tissue-homing properties. P Natl Acad Sci USA 107: 3006-3011.
16. Binder M, Kochs G, Bartenschlager R & Lohmann V (2007) Hepatitis C virus escape from the interferon regulatory factor 3 pathway by a passive and active evasion strategy. Hepatology 46: 1365-1374.
17. Binder M, Eberle F, Seitz S, Mucke N, Huber CM, Kiani N, Kaderali L, Lohmann V, Dalpke A & Bartenschlager R (2011) Molecular mechanism of signal perception and integration by the innate immune sensor retinoic acid-inducible gene-I (RIG-I). J Biol Chem 286: 27278-27287.
18. Blackburn SD, Shin H, Haining WN, Zou T, Workman CJ, Polley A, Betts MR, Freeman GJ, Vignali DA & Wherry EJ (2009) Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection. Nat Immunol 10: 29-37.
19. Blindenbacher A, Duong FH, Hunziker L et al. (2003) Expression of hepatitis C virus proteins inhibits interferon alpha signaling in the liver of transgenic mice. Gastroenterology 124: 1465-1475.
20. Bode JG, Ludwig S, Ehrhardt C, Albrecht U, Erhardt A, Schaper F, Heinrich PC & Haussinger D (2003) IFN-alpha antagonistic activity of HCV core protein involves induction of suppressor of cytokine signaling-3. FASEB J 17: 488-490.
21. Boettler T, Spangenberg HC, Neumann-Haefelin C, Panther E, Urbani S, Ferrari C, Blum HE, von Weizsacker F & Thimme R (2005) T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection. J Virol 79: 7860-7867.
22. Bowen DG & Walker CM (2005) Mutational escape from CD8+ T cell immunity: HCV evolution, from chimpanzees to man. J Exp Med 201: 1709-1714.
23. Bowen DG, Shoukry NH, Grakoui A et al. (2008) Variable patterns of programmed death-1 expression on fully functional memory T cells after spontaneous resolution of hepatitis C virus infection. J Virol 82: 5109-5114.
24. Brimacombe CL, Grove J, Meredith LW et al. (2011) Neutralizing antibody-resistant hepatitis C virus cell-to-cell transmission. J Virol 85: 596-605.
25. Brown EA, Zhang H, Ping LH & Lemon SM (1992) Secondary structure of the 5′ nontranslated regions of hepatitis C virus and pestivirus genomic RNAs. Nucleic Acids Res 20: 5041-5045.
26. Bukh J, Apgar CL, Govindarajan S, Emerson SU & Purcell RH (2001) Failure to infect rhesus monkeys with hepatitis C virus strains of genotypes 1a, 2a or 3a. J Viral Hepat 8: 228-231.
27. Cabrera R, Tu Z, Xu Y, Firpi RJ, Rosen HR, Liu C & Nelson DR (2004) An immunomodulatory role for CD4(+)CD25(+) regulatory T lymphocytes in hepatitis C virus infection. Hepatology 40: 1062-1071.
28. Callendret B & Walker C (2011) A siege of hepatitis: immune boost for viral hepatitis. Nat Med 17: 252-253.
29. Chang KM, Rehermann B, McHutchison JG, Pasquinelli C, Southwood S, Sette A & Chisari FV (1997) Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus. J Clin Invest 100: 2376-2385.
30. Cheent K & Khakoo SI (2011) Natural killer cells and hepatitis C: action and reaction. Gut 60: 268-278.
31. Chen L, Borozan I, Feld J, Sun J, Tannis LL, Coltescu C, Heathcote J, Edwards AM & McGilvray ID (2005) Hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infection. Gastroenterology 128: 1437-1444.
32. Cheng G, Zhong J & Chisari FV (2006) Inhibition of dsRNA-induced signaling in hepatitis C virus-infected cells by NS3 protease-dependent and -independent mechanisms. P Natl Acad Sci USA 103: 8499-8504.
33. Chisari FV (2005) Unscrambling hepatitis C virus-host interactions. Nature 436: 930-932.
34. Cooper S, Erickson AL, Adams EJ, Kansopon J, Weiner AJ, Chien DY, Houghton M, Parham P & Walker CM (1999) Analysis of a successful immune response against hepatitis C virus. Immunity 10: 439-449.
35. Cox AL, Mosbruger T, Lauer GM, Pardoll D, Thomas DL & Ray SC (2005a) Comprehensive analyses of CD8+ T cell responses during longitudinal study of acute human hepatitis C. Hepatology 42: 104-112.
36. Cox AL, Mosbruger T, Mao Q et al. (2005b) Cellular immune selection with hepatitis C virus persistence in humans. J Exp Med 201: 1741-1752.
37. Crispe IN (2011) Liver antigen-presenting cells. J Hepatol 54: 357-365.
38. Crotta S, Stilla A, Wack A et al. (2002) Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein. J Exp Med 195: 35-41.
39. Crotta S, Brazzoli M, Piccioli D, Valiante NM & Wack A (2010) Hepatitis C virions subvert natural killer cell activation to generate a cytokine environment permissive for infection. J Hepatol 52: 183-190.
40. David M (2010) Interferons and microRNAs. J Interferon Cytokine Res 30: 825-828.
41. Day CL, Lauer GM, Robbins GK, McGovern B, Wurcel AG, Gandhi RT, Chung RT & Walker BD (2002) Broad specificity of virus-specific CD4+ T-helper-cell responses in resolved hepatitis C virus infection. J Virol 76: 12584-12595.
42. Dazert E, Neumann-Haefelin C, Bressanelli S et al. (2009) Loss of viral fitness and cross-recognition by CD8+ T cells limit HCV escape from a protective HLA-B27-restricted human immune response. J Clin Invest 119: 376-386.
43. Diegelmann J, Beigel F, Zitzmann K, Kaul A, Goke B, Auernhammer CJ, Bartenschlager R, Diepolder HM & Brand S (2010) Comparative analysis of the lambda-interferons IL-28A and IL-29 regarding their transcriptome and their antiviral properties against hepatitis C virus. PLoS ONE 5: e15200.
44. Diepolder HM, Zachoval R, Hoffmann RM, Wierenga EA, Santantonio T, Jung MC, Eichenlaub D & Pape GR (1995) Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet 346: 1006-1007.
45. Diepolder HM, Gerlach JT, Zachoval R et al. (1997) Immunodominant CD4(+) T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection. J Virol 71: 6011-6019.
46. Dowd KA, Netski DM, Wang XH, Cox AL & Ray SC (2009) Selection pressure from neutralizing antibodies drives sequence evolution during acute infection with hepatitis C virus. Gastroenterology 136: 2377-2386.
47. Dreux MN, Gastaminza P, Wieland SF & Chisari FV (2009) The autophagy machinery is required to initiate hepatitis C virus replication. P Natl Acad Sci USA 106: 14046-14051.
48. Duong FH, Filipowicz M, Tripodi M, La Monica N & Heim MH. (2004) Hepatitis C virus inhibits interferon signaling through up-regulation of protein phosphatase 2A. Gastroenterology 126: 263-277.
49. Dupuis SP, Jouanguy E, Al Hajjar S et al. (2003) Impaired response to interferon-alpha/beta and lethal viral disease in human STAT1 deficiency. Nat Genet 33: 388-391.
50. Erickson AL, Kimura Y, Igarashi S, Eichelberger J, Houghton M, Sidney J, McKinney D, Sette A, Hughes AL & Walker CM (2001) The outcome of hepatitis C virus infection is predicted by escape mutations in epitopes targeted by cytotoxic T lymphocytes. Immunity 15: 883-895.
51. Falkowska E, Kajumo F, Garcia E, Reinus J & Dragic T (2007) Hepatitis C virus envelope glycoprotein E2 glycans modulate entry, CD81 binding, and neutralization. J Virol 81: 8072-8079.
52. Farag MMS, Weigand K, Encke J & Momburg F (2011) Activation of natural killer cells by hepatitis C virus particles in vitro. Clin Exp Immunol 163: 352-362.
53. Farci P, Alter HJ, Wong DC, Miller RH, Govindarajan S, Engle R, Shapiro M & Purcell RH (1994) Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization. P Natl Acad Sci USA 91: 7792-7796.
54. Farci P, Shimoda A, Wong D, Cabezon T, DeGioannis D, Strazzera A, Shimizu Y, Shapiro M, Alter HJ & Purcell RH (1996) Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein. P Natl Acad Sci USA 93: 15394-15399.
55. Fitzmaurice K, Petrovic D, Ramamurthy N et al. (2011) Molecular footprints reveal the impact of the protective HLA-A7*03 allele in hepatitis C virus infection. Gut 60: 1563-1571.
56. Fleming VM, Harcourt G, Barnes E & Klenerman P (2010) Virological footprint of CD4+ T-cell responses during chronic hepatitis C virus infection. J Gen Virol 91: 1396-1406.
57. Fletcher NF, Yang JP, Farquhar MJ et al. (2010) Hepatitis C virus infection of neuroepithelioma cell lines. Gastroenterology 139: 1365-1374.
58. Foy E, Li K, Wang C, Sumpter Jr R, Ikeda M, Lemon SM & Gale Jr M (2003) Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease. Science 300: 1145-1148.
59. Franceschini D, Paroli M, Francavilla V, Videtta M, Morrone S, Labbadia G, Cerino A, Mondelli MU & Barnaba V (2009) PD-L1 negatively regulates CD4+CD25+Foxp3+ Tregs by limiting STAT-5 phosphorylation in patients chronically infected with HCV. J Clin Invest 119: 551-564.
60. Frese M, Pietschmann T, Moradpour D, Haller O & Bartenschlager R (2001) Interferon-alpha inhibits hepatitis C virus subgenomic RNA replication by an MxA-independent pathway. J Gen Virol 82: 723-733.
61. Frese M, Schwarzle V, Barth K, Krieger N, Lohmann V, Mihm S, Haller O & Bartenschlager R (2002) Interferon-gamma inhibits replication of subgenomic and genomic hepatitis C virus RNAs. Hepatology 35: 694-703.
62. Fuller MJ, Shoukry NH, Gushima T, Bowen DG, Callendret B, Campbell KJ, Hasselschwert DL, Hughes AL & Walker CM (2010) Selection-driven immune escape is not a significant factor in the failure of CD4 T cell responses in persistent hepatitis C virus infection. Hepatology 51: 378-387.
63. Gale M & Katze MG (1998) Molecular mechanisms of interferon resistance mediated by viral-directed inhibition of PKR, the interferon-induced protein kinase. Pharmacol Ther 78: 29-46.
64. Garaigorta U & Chisari FV (2009) Hepatitis C virus blocks interferon effector function by inducing protein kinase R phosphorylation. Cell Host Microbe 6: 513-522.
65. Gaudieri S, Rauch A, Park LP et al. (2006) Evidence of viral adaptation to HLA class I-restricted immune pressure in chronic hepatitis C virus infection. J Virol 80: 11094-11104.
66. Ge D, Fellay J, Thompson AJ et al. (2009) Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 461: 399-401.
67. Gerlach JT, Diepolder HM, Jung MC, Gruener NH, Schraut WW, Zachoval R, Hoffmann R, Schirren CA, Santantonio T & Pape GR (1999) Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C. Gastroenterology 117: 933-941.
68. Golden-Mason L, Palmer B, Klarquist J, Mengshol JA, Castelblanco N & Rosen HR (2007) Upregulation of PD-1 expression on circulating and intrahepatic hepatitis C virus-specific CD8+ T cells associated with reversible immune dysfunction. J Virol 81: 9249-9258.
69. Golden-Mason L, Madrigal-Estebas L, McGrath E, Conroy MJ, Ryan EJ, Hegarty JE, O'Farrelly C & Doherty DG (2008) Altered natural killer cell subset distributions in resolved and persistent hepatitis C virus infection following single source exposure. Gut 57: 1121-1128.
70. Golden-Mason L, Palmer BE, Kassam N, Townshend-Bulson L, Livingston S, McMahon BJ, Castelblanco N, Kuchroo V, Gretch DR & Rosen HR (2009) Negative immune regulator Tim-3 is overexpressed on T cells in hepatitis C virus infection and its blockade rescues dysfunctional CD4+ and CD8+ T cells. J Virol 83: 9122-9130.
71. Grafmüller S, Billerbeck E, Blum HE, Neumann-Haefelin C & Thimme R (2011) Differential antigen-specificity of hepatitis C virus specific IL-17- and IFN-γ-producing CD8+ T cells during chronic infection. J Inf Dis in press.
72. Grakoui A, Shoukry NH, Woollard DJ, Han JH, Hanson HL, Ghrayeb J, Murthy KK, Rice CM & Walker CM (2003) HCV persistence and immune evasion in the absence of memory T cell help. Science 302: 659-662.
73. Gruner NH, Gerlach TJ, Jung MC et al. (2000) Association of hepatitis C virus-specific CD8+ T cells with viral clearance in acute hepatitis C. J Infect Dis 181: 1528-1536.
74. Guo JT, Sohn JA, Zhu Q & Seeger C (2004) Mechanism of the interferon alpha response against hepatitis C virus replicons. Virology 325: 71-81.
75. von Hahn T, Yoon JC, Alter H, Rice CM, Rehermann B, Balfe P & McKeating JA (2007) Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo. Gastroenterology 132: 667-678.
76. Haller O & Weber F (2007) Pathogenic viruses: smart manipulators of the interferon system. Curr Top Microbiol Immunol 316: 315-334.
77. Heeg MH, Ulsenheimer A, Gruner NH et al. (2009) FOXP3 expression in hepatitis C virus-specific CD4+ T cells during acute hepatitis C. Gastroenterology 137: 1280-1288.
78. Heim MH, Moradpour D & Blum HE (1999) Expression of hepatitis C virus proteins inhibits signal transduction through the Jak-STAT pathway. J Virol 73: 8469-8475.
79. Helbig KJ, Lau DT, Semendric L, Harley HA & Beard MR (2005) Analysis of ISG expression in chronic hepatitis C identifies viperin as a potential antiviral effector. Hepatology 42: 702-710.
80. Helle F, Goffard A, Morel V, Duverlie G, McKeating J, Keck ZY, Foung S, Penin F, Dubuisson J & Voisset C (2007) The neutralizing activity of anti-hepatitis C virus antibodies is modulated by specific glycans on the E2 envelope protein. J Virol 81: 8101-8111.
81. Hong X, Yu RB, Sun NX, Wang B, Xu YC & Wu GL (2005) Human leukocyte antigen class II DQB1*0301, DRB1*1101 alleles and spontaneous clearance of hepatitis C virus infection: a meta-analysis. World J Gastroenterol 11: 7302-7307.
82. Jo J, Aichele U, Kersting N et al. (2009) Analysis of CD8+ T-cell-mediated inhibition of hepatitis C virus replication using a novel immunological model. Gastroenterology 136: 1391-1401.
83. Jo J, Lohmann V, Bartenschlager R & Thimme R (2011) Experimental models to study the immunobiology of hepatitis C virus. J Gen Virol 92: 477-493.
84. Jopling CL, Yi M, Lancaster AM, Lemon SM & Sarnow P (2005) Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science 309: 1577-1581.
85. Kang JI, Kwon SN, Park SH, Kim YK, Choi SY, Kim JP & Ahn BY (2009) PKR protein kinase is activated by hepatitis C virus and inhibits viral replication through translational control. Virus Res 142: 51-56.
86. Kaplan DE, Sugimoto K, Newton K et al. (2007) Discordant role of CD4 T-cell response relative to neutralizing antibody and CD8 T-cell responses in acute hepatitis C. Gastroenterology 132: 654-666.
87. Kasprowicz V, Schulze Zur Wiesch J, Kuntzen T et al. (2008) High level of PD-1 expression on hepatitis C virus (HCV)-specific CD8+ and CD4+ T cells during acute HCV infection, irrespective of clinical outcome. J Virol 82: 3154-3160.
88. Kawai T & Akira S (2010) The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 11: 373-384.
89. Ke PY & Chen SS (2011) Activation of the unfolded protein response and autophagy after hepatitis C virus infection suppresses innate antiviral immunity in vitro. J Clin Invest 121: 37-56.
90. Khakoo SI, Thio CL, Martin MP et al. (2004) HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 305: 872-874.
91. Kim AY, Kuntzen T, Timm J et al. (2011) Spontaneous control of HCV is associated with expression of HLA-B 57 and preservation of targeted epitopes. Gastroenterology 140: 686-696.
92. Kimura Y, Gushima T, Rawale S, Kaumaya P & Walker CM (2005) Escape mutations alter proteasome processing of major histocompatibility complex class I-restricted epitopes in persistent hepatitis C virus infection. J Virol 79: 4870-4876.
93. Knapp S, Warshow U, Hegazy D et al. (2010) Consistent beneficial effects of killer cell immunoglobulin-like receptor 2DL3 and group 1 human leukocyte antigen-C following exposure to hepatitis C virus. Hepatology 51: 1168-1175.
94. Kuniholm MH, Kovacs A, Gao X et al. (2010) Specific human leukocyte antigen class I and II alleles associated with hepatitis C virus viremia. Hepatology 51: 1514-1522.
95. Lande R & Gilliet M (2010) Plasmacytoid dendritic cells: key players in the initiation and regulation of immune responses. Ann NY Acad Sci 1183: 89-103.
96. Larkin J, Bost A, Glass JI & Tan SL (2006) Cytokine-activated natural killer cells exert direct killing of hepatoma cells harboring hepatitis C virus replicons. J Interferon Cytokine Res 26: 854-865.
97. Lauer GM & Walker BD (2001) Hepatitis C virus infection. N Engl J Med 345: 41-52.
98. Lauer GM, Ouchi K, Chung RT et al. (2002) Comprehensive analysis of CD8(+)-T-cell responses against hepatitis C virus reveals multiple unpredicted specificities. J Virol 76: 6104-6113.
99. Lechner F, Wong DK, Dunbar PR, Chapman R, Chung RT, Dohrenwend P, Robbins G, Phillips R, Klenerman P & Walker BD (2000) Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med 191: 1499-1512.
100. Lee HK, Lund JM, Ramanathan B, Mizushima N & Iwasaki A (2007) Autophagy-dependent viral recognition by plasmacytoid dendritic cells. Science 315: 1398-1401.
101. Li Y, Zhang T, Ho C, Orange JS, Douglas SD & Ho WZ (2004) Natural killer cells inhibit hepatitis C virus expression. J Leukoc Biol 76: 1171-1179.
102. Li K, Foy E, Ferreon JC, Nakamura M, Ferreon AC, Ikeda M, Ray SC, Gale Jr M & Lemon SM (2005) Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. P Natl Acad Sci USA 102: 2992-2997.
103. Logvinoff C, Major ME, Oldach D, Heyward S, Talal A, Balfe P, Feinstone SM, Alter H, Rice CM & McKeating JA (2004) Neutralizing antibody response during acute and chronic hepatitis C virus infection. P Natl Acad Sci USA 101: 10149-10154.
104. Luquin E, Larrea E, Civeira MP, Prieto Js & Aldabe R (2007) HCV structural proteins interfere with interferon-alpha Jak/STAT signalling pathway. Antiviral Res 76: 194-197.
105. Major ME, Dahari H, Mihalik K, Puig M, Rice CM, Neumann AU & Feinstone SM (2004) Hepatitis C virus kinetics and host responses associated with disease and outcome of infection in chimpanzees. Hepatology 39: 1709-1720.
106. Malathi K, Dong B, Gale Jr M & Silverman RH (2007) Small self-RNA generated by RNase L amplifies antiviral innate immunity. Nature 448: 816-819.
107. Marcello T, Grakoui A, Barba-Spaeth G, Machlin ES, Kotenko SV, MacDonald MR & Rice CM (2006) Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics. Gastroenterology 131: 1887-1898.
108. Marukian S, Jones CT, Andrus L, Evans MJ, Ritola KD, Charles ED, Rice CM & Dustin LB (2008) Cell culture-produced hepatitis C virus does not infect peripheral blood mononuclear cells. Hepatology 48: 1843-1850.
109. Matloubian M, Concepcion RJ & Ahmed R (1994) CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection. J Virol 68: 8056-8063.
110. McKiernan SM, Hagan R, Curry M, McDonald GS, Kelly A, Nolan N, Walsh A, Hegarty J, Lawlor E & Kelleher D (2004) Distinct MHC class I and II alleles are associated with hepatitis C viral clearance, originating from a single source. Hepatology 40: 108-114.
111. McMahan RH, Golden-Mason L, Nishimura MI, McMahon BJ, Kemper M, Allen TM, Gretch DR & Rosen HR (2010) Tim-3 expression on PD-1+ HCV-specific human CTLs is associated with viral persistence, and its blockade restores hepatocyte-directed in vitro cytotoxicity. J Clin Invest 120: 4546-4557.
112. Merani S, Petrovic D, James I et al. (2011) Effect of immune pressure on hepatitis C virus evolution: insights from a single-source outbreak. Hepatology 53: 396-405.
113. Meyer-Olson D, Shoukry NH, Brady KW, Kim H, Olson DP, Hartman K, Shintani AK, Walker CM & Kalams SA (2004) Limited T cell receptor diversity of HCV-specific T cell responses is associated with CTL escape. J Exp Med 200: 307-319.
114. Meylan E, Curran J, Hofmann K, Moradpour D, Binder M, Bartenschlager R & Tschopp J (2005) Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437: 1167-1172.
115. Missale G, Bertoni R, Lamonaca V, Valli A, Massari M, Mori C, Rumi MG, Houghton M, Fiaccadori F & Ferrari C (1996) Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response. J Clin Invest 98: 706-714.
116. Montes-Cano MA, Caro-Oleas JL, Romero-Gómez M, Diago MS, Andrade R, Carmona I, Aguilar Reina J, Núñez-Roldán A & González-Escribano MF (2005) HLA-C and KIR genes in hepatitis C virus infection. Hum Immunol 66: 1106-1109.
117. Nakamoto N, Kaplan DE, Coleclough J et al. (2008) Functional restoration of HCV-specific CD8 T cells by PD-1 blockade is defined by PD-1 expression and compartmentalization. Gastroenterology 134: 1927-1937.
118. Nakamoto N, Cho H, Shaked A et al. (2009) Synergistic reversal of intrahepatic HCV-specific CD8 T cell exhaustion by combined PD-1/CTLA-4 blockade. PLoS Pathog 5: e1000313.
119. Netski DM, Mosbruger T, Depla E, Maertens G, Ray SC, Hamilton RG, Roundtree S, Thomas DL, McKeating J & Cox A (2005) Humoral immune response in acute hepatitis C virus infection. Clin Infect Dis 41: 667-675.
120. Neumann AU, Lam NP, Dahari H, Gretch DR, Wiley TE, Layden TJ & Perelson AS (1998) Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy. Science 282: 103-107.
121. Neumann-Haefelin C, McKiernan S, Ward S et al. (2006) Dominant influence of an HLA-B27 restricted CD8+ T cell response in mediating HCV clearance and evolution. Hepatology 43: 563-572.
122. Neumann-Haefelin C, Timm J, Spangenberg HC, Wischniowski N, Nazarova N, Kersting N, Roggendorf M, Allen TM, Blum HE & Thimme R (2008) Virological and immunological determinants of intrahepatic virus-specific CD8+ T-cell failure in chronic hepatitis C virus infection. Hepatology 47: 1824-1836.
123. Neumann-Haefelin C, Timm J, Schmidt J et al. (2010) Protective effect of human leukocyte antigen B27 in hepatitis C virus infection requires the presence of a genotype-specific immunodominant CD8+ T-cell epitope. Hepatology 51: 54-62.
124. Northfield JW, Kasprowicz V, Lucas M et al. (2008) CD161 expression on hepatitis C virus-specific CD8+ T cells suggests a distinct pathway of T cell differentiation. Hepatology 47: 396-406.
125. Oliviero B, Varchetta S, Paudice E, Michelone G, Zaramella M, Mavilio D, De Filippi F, Bruno S & Mondelli MU (2009) Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections. Gastroenterology 137: 1151-1160.
126. Osburn WO, Fisher BE, Dowd KA, Urban G, Liu L, Ray SC, Thomas DL & Cox AL (2010) Spontaneous control of primary hepatitis C virus infection and immunity against persistent reinfection. Gastroenterology 138: 315-324.
127. Osterlund PI, Pietil+ñ TE, Veckman V, Kotenko SV & Julkunen I (2007) IFN regulatory factor family members differentially regulate the expression of type III IFN (IFN-lambda) genes. J Immunol 179: 3434-3442.
128. Penna A, Pilli M, Zerbini A, Orlandini A, Mezzadri S, Sacchelli L, Missale G & Ferrari C (2007) Dysfunction and functional restoration of HCV-specific CD8 responses in chronic hepatitis C virus infection. Hepatology 45: 588-601.
129. Pestka JM, Zeisel MB, Blaser E et al. (2007) Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C. P Natl Acad Sci USA 104: 6025-6030.
130. Pflugheber J, Fredericksen B, Sumpter Jr R, Wang C, Ware F, Sodora DL & Gale Jr M (2002) Regulation of PKR and IRF-1 during hepatitis C virus RNA replication. P Natl Acad Sci USA 99: 4650-4655.
131. Ploss A, Evans MJ, Gaysinskaya VA, Panis M, You H, de Jong YP & Rice CM (2009) Human occludin is a hepatitis C virus entry factor required for infection of mouse cells. Nature 457: 882-886.
132. Poenisch M & Bartenschlager R (2010) New insights into structure and replication of the hepatitis C virus and clinical implications. Semin Liver Dis 30: 333-347.
133. Quinkert D, Bartenschlager R & Lohmann V (2005) Quantitative analysis of the hepatitis C virus replication complex. J Virol 79: 13594-13605.
134. Radziewicz H, Ibegbu CC, Fernandez ML et al. (2007) Liver-infiltrating lymphocytes in chronic human hepatitis C virus infection display an exhausted phenotype with high levels of PD-1 and low levels of CD127 expression. J Virol 81: 2545-2553.
135. Radziewicz H, Ibegbu CC, Hon H et al. (2008) Impaired hepatitis C virus (HCV)-specific effector CD8+ T cells undergo massive apoptosis in the peripheral blood during acute HCV infection and in the liver during the chronic phase of infection. J Virol 82: 9808-9822.
136. Randall RE & Goodbourn S (2008) Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J Gen Virol 89: 1-47.
137. Rauch A, Laird R, McKinnon E, Telenti A, Furrer H, Weber R, Smillie D, Gaudieri S & Swiss HIV CS (2007) Influence of inhibitory killer immunoglobulin-like receptors and their HLA-C ligands on resolving hepatitis C virus infection. Tissue Antigens 69(Suppl 1): 237-240.
138. Rauch A, James I, Pfafferott K et al. (2009) Divergent adaptation of hepatitis C virus genotypes 1 and 3 to human leukocyte antigen-restricted immune pressure. Hepatology 50: 1017-1029.
139. Ray SC, Fanning L, Wang XH, Netski DM, Kenny-Walsh E & Thomas DL (2005) Divergent and convergent evolution after a common-source outbreak of hepatitis C virus. J Exp Med 201: 1753-1759.
140. Rehermann B (2009) Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence. J Clin Invest 119: 1745-1754.
141. Romero V, Azocar J, Zúñiga J, Clavijo OP, Terreros D, Gu X, Husain Z, Chung RT, Amos C & Yunis EJ (2008) Interaction of NK inhibitory receptor genes with HLA-C and MHC class II alleles in Hepatitis C virus infection outcome. Mol Immunol 45: 2429-2436.
142. Rowan AG, Fletcher JM, Ryan EJ, Moran B, Hegarty JE, O'Farrelly C & Mills KH (2008) Hepatitis C virus-specific Th17 cells are suppressed by virus-induced TGF-beta. J Immunol 181: 4485-4494.
143. Ruhl M, Knuschke T, Schewior K et al. (2011) CD8(+)T-cell response promotes evolution of hepatitis C virus nonstructural proteins. Gastroenterology 140: 2064-2073.
144. Rushbrook SM, Ward SM, Unitt E, Vowler SL, Lucas M, Klenerman P & Alexander GJ (2005) Regulatory T cells suppress in vitro proliferation of virus-specific CD8+ T cells during persistent hepatitis C virus infection. J Virol 79: 7852-7859.
145. Sabo MC, Luca VC, Prentoe J et al. (2011) Neutralizing monoclonal antibodies against hepatitis C virus E2 protein bind discontinuous epitopes and inhibit infection at a postattachment step. J Virol 85: 7005-7019.
146. Saito T, Owen DM, Jiang F, Marcotrigiano J & Gale Jr M (2008) Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA. Nature 454: 523-527.
147. Saitoh T & Akira S (2010) Regulation of innate immune responses by autophagy-related proteins. J Cell Biol 189: 925-935.
148. Sarasin-Filipowicz M, Oakeley EJ, Duong FH, Christen V, Terracciano L, Filipowicz W & Heim MH (2008) Interferon signaling and treatment outcome in chronic hepatitis C. P Natl Acad Sci USA 105: 7034-7039.
149. Sarasin-Filipowicz M, Krol J, Markiewicz I, Heim MH & Filipowicz W (2009) Decreased levels of microRNA miR-122 in individuals with hepatitis C responding poorly to interferon therapy. Nat Med 15: 31-33.
150. Schindler C & Plumlee C (2008) Inteferons pen the JAK-STAT pathway. Semin Cell Dev Biol 19: 311-318.
151. Schlaphoff V, Lunemann S, Suneetha PV et al. (2011) Dual function of the NK cell receptor 2B4 (CD244) in the regulation of HCV-specific CD8+ T cells. PLoS Pathog 7: e1002045.
152. Schlee M, Roth A, Hornung V et al. (2009) Recognition of 5′ triphosphate by RIG-I helicase requires short blunt double-stranded RNA as contained in panhandle of negative-strand virus. Immunity 31: 25-34.
153. Schmidt A, Schwerd T, Hamm W et al. (2009) 5′-Triphosphate RNA requires base-paired structures to activate antiviral signaling via RIG-I. P Natl Acad Sci USA 106: 12067-12072.
154. Schmidt J, Thimme R & Neumann-Haefelin C (2011) Host genetics in immune-mediated hepatitis C virus clearance. Biomark Med 5: 155-169.
155. Schoggins JW, Wilson SJ, Panis M, Murphy MY, Jones CT, Bieniasz P & Rice CM (2011) A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 472: 481-485.
156. Schulze Zur Wiesch J, Lauer GM, Day CL et al. (2005) Broad repertoire of the CD4+ Th cell response in spontaneously controlled hepatitis C virus infection includes dominant and highly promiscuous epitopes. J Immunol 175: 3603-3613.
157. Seifert U, Liermann H, Racanelli V et al. (2004) Hepatitis C virus mutation affects proteasomal epitope processing. J Clin Invest 114: 250-259.
158. Semmo N, Day CL, Ward SM, Lucas M, Harcourt G, Loughry A & Klenerman P (2005) Preferential loss of IL-2-secreting CD4+ T helper cells in chronic HCV infection. Hepatology 41: 1019-1028.
159. Sene D, Levasseur F, Abel M et al. (2010) Hepatitis C virus (HCV) evades NKG2D-dependent NK cell responses through NS5A-mediated imbalance of inflammatory cytokines. PLoS Pathog 6: e1001184.
160. Shepard CW, Finelli L & Alter MJ (2005) Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 5: 558-567.
161. Sheppard P, Kindsvogel W, Xu W et al. (2003) IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat Immunol 4: 63-68.
162. Shin EC, Park SH, Demino M et al. (2011) Delayed induction, not impaired recruitment of specific CD8(+) T cells, causes the late onset of acute hepatitis C. Gastroenterology 141: 686-695.
163. Shoukry NH, Grakoui A, Houghton M, Chien DY, Ghrayeb J, Reimann KA & Walker CM (2003) Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection. J Exp Med 197: 1645-1655.
164. Shrivastava S, Raychoudhuri A, Steele R, Ray R & Ray RB (2011) Knockdown of autophagy enhances the innate immune response in hepatitis C virus-infected hepatocytes. Hepatology 53: 406-414.
165. Shuai K & Liu B (2005) Regulation of gene-activation pathways by PIAS proteins in the immune system. Nat Rev Immunol 5: 593-605.
166. Sir D & Ou JH (2010) Autophagy in viral replication and pathogenesis. Mol Cells 29: 1-7.
167. Sir D, Chen WL, Choi J, Wakita T, Yen TS & Ou JH (2008) Induction of incomplete autophagic response by hepatitis C virus via the unfolded protein response. Hepatology 48: 1054-1061.
168. Smyk-Pearson S, Golden-Mason L, Klarquist J, Burton Jr JR, Tester IA, Wang CC, Culbertson N, Vandenbark AA & Rosen HR (2008) Functional suppression by FoxP3+CD4+CD25(high) regulatory T cells during acute hepatitis C virus infection. J Infect Dis 197: 46-57.
169. Soderholm J, Ahlen G, Kaul A et al. (2006) Relation between viral fitness and immune escape within the hepatitis C virus protease. Gut 55: 266-274.
170. Sommereyns C, Paul S, Staeheli P & Michiels T (2008) IFN-lambda (IFN-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo. PLoS Pathog 4: e1000017.
171. Spangenberg HC, Viazov S, Kersting N, Neumann-Haefelin C, McKinney D, Roggendorf M, von Weizsacker F, Blum HE & Thimme R (2005) Intrahepatic CD8+ T-cell failure during chronic hepatitis C virus infection. Hepatology 42: 828-837.
172. Stegmann KA, Björkström NK, Veber H et al. (2010) Interferon-alpha-induced TRAIL on natural killer cells is associated with control of hepatitis C virus infection. Gastroenterology 138: 1885-1897.
173. Su AI, Pezacki JP, Wodicka L et al. (2002) Genomic analysis of the host response to hepatitis C virus infection. P Natl Acad Sci USA 99: 15669-15674.
174. Sugimoto K, Ikeda F, Stadanlick J, Nunes FA, Alter HJ & Chang KM (2003) Suppression of HCV-specific T cells without differential hierarchy demonstrated ex vivo in persistent HCV infection. Hepatology 38: 1437-1448.
175. Suppiah V, Moldovan M, Ahlenstiel G et al. (2009) IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy. Nat Genet 41: 1100-1104.
176. Tacke R, Lee HC, Goh C, Courtney J, Polyak SJ, Rosen HR & Hahn YS (2011) Myeloid suppressor cells induced by hepatitis C virus suppress T cell responses through the production of reactive oxygen species. Hepatology in press.
177. Takahashi K, Asabe S, Wieland S, Garaigorta U, Gastaminza P, Isogawa M & Chisari FV (2010) Plasmacytoid dendritic cells sense hepatitis C virus-infected cells, produce interferon, and inhibit infection. P Natl Acad Sci USA 107: 7431-7436.
178. Takaki A, Wiese M, Maertens G, Depla E, Seifert U, Liebetrau A, Miller JL, Manns MP & Rehermann B (2000) Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C. Nat Med 6: 578-582.
179. Tanaka Y, Nishida N, Sugiyama M et al. (2009) Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Nat Genet 41: 1105-1109.
180. Tardif KD, Mori K & Siddiqui A (2002) Hepatitis C virus subgenomic replicons induce endoplasmic reticulum stress activating an intracellular signaling pathway. J Virol 76: 7453-7459.
181. Taylor DR, Shi ST, Romano PR, Barber GN & Lai MC (1999) Inhibition of the interferon-inducible protein kinase PKR by HCV E protein. Science 285: 107-110.
182. Taylor DR, Puig M, Darnell ME, Mihalik K & Feinstone SM (2005) New antiviral pathway that mediates hepatitis C virus replicon interferon sensitivity through ADAR1. J Virol 79: 6291-6298.
183. Tester I, Smyk-Pearson S, Wang P, Wertheimer A, Yao E, Lewinsohn DM, Tavis JE & Rosen HR (2005) Immune evasion versus recovery after acute hepatitis C virus infection from a shared source. J Exp Med 201: 1725-1731.
184. Thimme R, Oldach D, Chang KM, Steiger C, Ray SC & Chisari FV (2001) Determinants of viral clearance and persistence during acute hepatitis C virus infection. J Exp Med 194: 1395-1406.
185. Thimme R, Bukh J, Spangenberg HC, Wieland S, Pemberton J, Steiger C, Govindarajan S, Purcell RH & Chisari FV (2002) Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease. P Natl Acad Sci USA 99: 15661-15668.
186. Thio CL, Gao X, Goedert JJ et al. (2002) HLA-Cw*04 and hepatitis C virus persistence. J Virol 76: 4792-4797.
187. Thomas DL, Thio CL, Martin MP et al. (2009) Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 461: 798-801.
188. Timm J, Lauer GM, Kavanagh DG et al. (2004) CD8 epitope escape and reversion in acute HCV infection. J Exp Med 200: 1593-1604.
189. Timm J, Li B, Daniels MG et al. (2007) Human leukocyte antigen-associated sequence polymorphisms in hepatitis C virus reveal reproducible immune responses and constraints on viral evolution. Hepatology 46: 339-349.
190. Timpe JM, Stamataki Z, Jennings A et al. (2008) Hepatitis C virus cell-cell transmission in hepatoma cells in the presence of neutralizing antibodies. Hepatology 47: 17-24.
191. Tseng CT & Klimpel GR (2002) Binding of the hepatitis C virus envelope protein E2 to CD81 inhibits natural killer cell functions. J Exp Med 195: 43-49.
192. Urbani S, Amadei B, Cariani E, Fisicaro P, Orlandini A, Missale G & Ferrari C (2005) The impairment of CD8 responses limits the selection of escape mutations in acute hepatitis C virus infection. J Immunol 175: 7519-7529.
193. Uzri D & Gehrke L (2009) Nucleotide sequences and modifications that determine RIG-I/RNA binding and signaling activities. J Virol 83: 4174-4184.
194. Walker CM (2010) Adaptive immunity to the hepatitis C virus. Adv Virus Res 78: 43-86.
195. Wang C, Pflugheber J, Sumpter Jr R, Sodora DL, Hui D, Sen GC & Gale Jr M (2003) Alpha interferon induces distinct translational control programs to suppress hepatitis C virus RNA replication. J Virol 77: 3898-3912.
196. Ward SM, Fox BC, Brown PJ, Worthington J, Fox SB, Chapman RW, Fleming KA, Banham AH & Klenerman P (2007) Quantification and localisation of FOXP3+ T lymphocytes and relation to hepatic inflammation during chronic HCV infection. J Hepatol 47: 316-324.
197. Wedemeyer H, He XS, Nascimbeni M, Davis AR, Greenberg HB, Hoofnagle JH, Liang TJ, Alter H & Rehermann B (2002) Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection. J Immunol 169: 3447-3458.
198. Weiner AJ, Erickson AL, Kansopon J, Crawford K, Muchmore E, Houghton M & Walker CM (1995) Association of cytotoxic T lymphocyte (CTL) escape mutations with persistent hepatitis C virus (HCV) infection. Princess Takamatsu Symp 25: 227-235.
199. West AP, Shadel GS & Ghosh S (2011) Mitochondria in innate immune responses. Nat Rev Immunol 11: 389-402.
200. Witteveldt J, Evans MJ, Bitzegeio J et al. (2009) CD81 is dispensable for hepatitis C virus cell-to-cell transmission in hepatoma cells. J Gen Virol 90: 48-58.
201. Xie ZC, Riezu-Boj JI, Lasarte JJ, Guillen J, Su JH, Civeira MP & Prieto J (1998) Transmission of hepatitis C virus infection to tree shrews. Virology 244: 513-520.
202. Xu X, Chen H, Cao X & Ben K (2007) Efficient infection of tree shrew (Tupaia belangeri) with hepatitis C virus grown in cell culture or from patient plasma. J Gen Virol 88: 2504-2512.
203. Yoneyama M & Fujita T (2009) RNA recognition and signal transduction by RIG-I-like receptors. Immunol Rev 227: 54-65.
204. Yoon JC, Shiina M, Ahlenstiel G & Rehermann B (2009) Natural killer cell function is intact after direct exposure to infectious hepatitis C virions. Hepatology 49: 12-21.
205. Yoshimura A, Naka T & Kubo M (2007) SOCS proteins, cytokine signalling and immune regulation. Nat Rev Immunol 7: 454-465.
206. Zeisel MB, Cosset FL & Baumert TF (2008) Host neutralizing responses and pathogenesis of hepatitis C virus infection. Hepatology 48: 299-307.
207. Zeisel MB, Fofana I, Fafi-Kremer S & Baumert TF (2011) Hepatitis C virus entry into hepatocytes: molecular mechanisms and targets for antiviral therapies. J Hepatol 54: 566-576.
208. Zhang P, Wu CG, Mihalik K, Virata-Theimer ML, Yu MY, Alter HJ & Feinstone SM (2007) Hepatitis C virus epitope-specific neutralizing antibodies in Igs prepared from human plasma. P Natl Acad Sci USA 104: 8449-8454.
209. Zignego AL, Giannini C, Monti M & Gragnani L (2007) Hepatitis C virus lymphotropism: lessons from a decade of studies. Dig Liver Dis 39(Suppl 1): S38-S45.